Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The natural history of Vestibular Schwannoma growth - prospective 40-year data from an unselected national cohort

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. PET imaging in patients with brain metastasis-report of the RANO/PET group

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Sex-specific gene and pathway modeling of inherited glioma risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. COVID-19 infection rate among tertiary referral center otorhinolaryngology healthcare workers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intracochlear Vestibular Schwannoma Presenting with Mixed Hearing Loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Objective Vestibular Test Battery and Patient Reported Outcomes in Cochlear Implant Recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Optimal management of vestibular schwannoma (VS) is still debated and thus international consensus has not been achieved. Treatment options are observation, radiotherapy, and surgery. Knowledge on the natural history of tumor growth is essential for choice of treatment modality. The aim is to present intra-/extrameatal tumor growth and management data from a prospective, unselected national cohort of patients diagnosed with VS during the period 1976-2015.

METHODS: Since 1976, all data from patients diagnosed with sporadic VS in Denmark have been referred to our national treatment center, where they have been entered prospectively into the national database. Data on tumor localization, growth, and treatment were retrieved. Growth definition: >2 mm by linear measurement, in accordance with the Tokyo 2001 consensus-meeting recommendations.

RESULTS: 3637 cases of VS were diagnosed, in which 1304 patients had surgery and 21 received radiotherapy post diagnosis. 2312 patients were observed with mean follow-up of 7.33 years. Of these, 434(19%; 102 intra-and 332 extrameatal tumors) changed to active treatment during the observation period due to tumor growth. 5 years after diagnosis, 21% of the intrameatal tumors exhibited growth during observation, whereas 37% of extrameatal tumors had grown, increasing to 25% intrameatal and 42% extrameatal after 10 years. Following growth, the intrameatal tumors were mostly observed further and the extrameatal mostly underwent surgery. Tumor growth occurred mainly within the first 5 years post diagnosis.

CONCLUSION: This natural history study documents the growth occurrence of both intra-and extrameatal VS during the first 12 years after diagnosis and should be used in patient counseling, management, and treatment decision making.

Original languageEnglish
JournalNeuro-Oncology
Volume23
Issue number5
Pages (from-to)827-836
Number of pages10
ISSN1522-8517
DOIs
Publication statusPublished - 5 May 2021

    Research areas

  • acoustic neuroma, conservative management, extrameatal, intrameatal, observation, tumor-growth/-size

ID: 61229774